Showing results (1-10 of 443) with videos related to
Sort By:
Pageof 45
Seminars in Oncology|March 1, 1982
The cardiotoxicity of anticancer agentsD D Von Hoff, M Rozencweig, M PiccartThe Journal of Urology|April 1, 1977
Estramustine phosphate: a specific chemotherapeutic agent?D D Von Hoff, M Rozencweig, M Slavik, et al.Anticancer Research|January 1, 1981
Cisplatin: impact of a new anticancer agent on current therapeutic strategiesM Rozencweig, R Abele, D D von Hoff, et al.Annals of Internal Medicine|June 1, 1977
Cis-diamminedichloroplatinum (II). A new anticancer drugM Rozencweig, D D von Hoff, M Slavik, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
The role of antitumor antibiotics in current oncologic practiceH L Davis, D D von Hoff, J E Henney, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Role of antitumor antibiotics in current oncologic practiceH L Davis, D D von Hoff, J E Henney, et al.Archiv Fur Geschwulstforschung|January 1, 1978
Effective adjuvant treatments. A brief review of U.S. clinical trialsA C Louie, M Rozencweig, D D von Hoff, et al.Cancer Chemotherapy and Pharmacology|January 1, 1979
m-AMSA and PALA: two new agents in cancer chemotherapyM Rozencweig, D D Von Hoff, R L Cysyk, et al.Cancer Treatment Reports|November 1, 1979
The delta and epsilon errors in the assessment of cancer clinical trialsM J Staquet, M Rozencweig, D D Von Hoff, et al.Cancer|February 1, 1981
Clinical trials with the hexitol derivatives in the U.SD F Chiuten, M Rozencweig, D D Von Hoff, et al.Pageof 45